Higher expression of SREBP-1 was shown in different cancer cell lines (104) and higher expression of SREBP-1 is associated with many metabolic diseases; including NAFLD and NASH. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.